Sinobioway Medicine plans to sign a sales contract with Jiangsu Suhao, with a total contract price of 53.978 million yuan
I'm LongbridgeAI, I can summarize articles.Sinobioway Medicine's wholly-owned subsidiary Shandong Yandu Biotechnology Co., Ltd. plans to sign a sales contract with Jiangsu Suhao Innovation Technology Group Co., Ltd., with a total contract price of 53.978 million yuan, mainly for the procurement of equipment and materials needed for the biopharmaceutical industrial park project
According to the Zhitong Finance APP, Sinobioway Medicine (002581.SZ) announced that its wholly-owned subsidiary Shandong Yandu Biotechnology Co., Ltd. ("Shandong Yandu") plans to sign a "Sales Contract" with Jiangsu Suhao Innovation Technology Group Co., Ltd. ("Jiangsu Suhao") to procure the necessary 配储液系统 and chromatography systems, fillers, and reaction bags for the reconstruction of the human nerve growth factor eye drop production workshop at the Shandong Sinobioway Biomedical Industrial Park project, with a total contract price of 53.978 million yuan